However, there is limited research on PSA test performance in AA populations, who experience distinct age-specific prostate cancer risk distributions (Wolf et al., 2010, Verges et al., 2017, US Preventive Services Task Force, 2018). This evidence concerns the gene KLK3 and prostate carcinoma.